[144] AGCO Corporation SEC Filing
AGCO submitted a Form 144 notice registering the proposed sale of 10,000 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $1,093,990.40 and an approximate sale date of 08/11/2025. The filing states 74,620,227 shares outstanding, so the 10,000-share block represents about 0.013% of the outstanding common stock and implies an approximate price of $109.40 per share.
The securities listed were acquired as restricted stock vesting in multiple tranches between 01/01/2021 and 02/07/2024 totaling 10,000 shares, and the filing also notes a prior sale of 5,000 shares on 08/08/2025 with gross proceeds of $557,500.00. The notice includes the representation that the seller is not aware of undisclosed material adverse information.
AGCO ha presentato un avviso Form 144 per registrare la proposta di vendita di 10,000 azioni ordinarie tramite Fidelity Brokerage Services sul NYSE, con un valore di mercato complessivo di $1,093,990.40 e una data di vendita approssimativa indicata al 08/11/2025. Il deposito riporta 74,620,227 azioni in circolazione, quindi il blocco da 10,000 azioni rappresenta circa il 0.013% del capitale ordinario in circolazione e implica un prezzo approssimativo di $109.40 per azione.
I titoli elencati sono stati acquisiti come restricted stock vesting in più tranche tra il 01/01/2021 e il 02/07/2024, per un totale di 10,000 azioni; il deposito indica inoltre una vendita precedente di 5,000 azioni in data 08/08/2025 con proventi lordi pari a $557,500.00. L'avviso include la dichiarazione che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate.
AGCO presentó un aviso Form 144 registrando la venta propuesta de 10,000 acciones ordinarias a través de Fidelity Brokerage Services en el NYSE, con un valor de mercado agregado de $1,093,990.40 y una fecha de venta aproximada del 08/11/2025. La presentación señala 74,620,227 acciones en circulación, por lo que el lote de 10,000 acciones representa alrededor del 0.013% del capital social en circulación e implica un precio aproximado de $109.40 por acción.
Los títulos listados fueron adquiridos como restricted stock vesting en varias tramos entre el 01/01/2021 y el 02/07/2024, por un total de 10,000 acciones, y la presentación también indica una venta previa de 5,000 acciones el 08/08/2025 con ingresos brutos de $557,500.00. El aviso incluye la declaración de que el vendedor no tiene conocimiento de información material adversa no divulgada.
AGCO는 Form 144 통지서를 제출하여 NYSE를 통해 Fidelity Brokerage Services에서 10,000 보통주를 매도할 예정임을 등록했으며, 총 시가 가치는 $1,093,990.40이고 예상 매각일은 08/11/2025로 기재되어 있습니다. 신고서에는 발행주식수 74,620,227주가 기재되어 있어 10,000주 블록은 발행주식의 약 0.013%에 해당하며 주당 약 $109.40의 가격을 의미합니다.
해당 증권은 restricted stock vesting으로 01/01/2021부터 02/07/2024 사이 여러 트랜치로 취득되어 총 10,000주이며, 신고서에는 또한 08/08/2025에 5,000주를 매각하여 총수익 $557,500.00을 올렸다고 기재되어 있습니다. 통지서에는 판매자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 진술도 포함되어 있습니다.
AGCO a déposé un avis Form 144 enregistrant la vente proposée de 10,000 actions ordinaires via Fidelity Brokerage Services sur le NYSE, pour une valeur de marché totale de $1,093,990.40 et une date de vente approximative indiquée au 08/11/2025. Le dossier indique 74,620,227 actions en circulation, de sorte que le lot de 10,000 actions représente environ 0.013% du capital ordinaire en circulation et implique un prix approximatif de $109.40 par action.
Les titres listés ont été acquis en tant que restricted stock vesting en plusieurs tranches entre le 01/01/2021 et le 02/07/2024, pour un total de 10,000 actions, et le dossier signale également une vente antérieure de 5,000 actions le 08/08/2025 pour un produit brut de $557,500.00. L'avis inclut la déclaration selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée.
AGCO hat eine Form-144-Mitteilung eingereicht, um den geplanten Verkauf von 10,000 Stammaktien über Fidelity Brokerage Services an der NYSE zu registrieren. Der Gesamtmarktwert beträgt $1,093,990.40, das ungefähre Verkaufsdatum ist mit 08/11/2025 angegeben. In der Einreichung werden 74,620,227 ausstehende Aktien genannt, sodass das 10,000-Aktien-Paket etwa 0.013% des ausstehenden Stammkapitals ausmacht und einen ungefähren Preis von $109.40 je Aktie impliziert.
Die aufgeführten Wertpapiere wurden als restricted stock vesting in mehreren Tranchen zwischen 01/01/2021 und 02/07/2024 erworben und summieren sich auf 10,000 Aktien. Die Einreichung erwähnt außerdem einen früheren Verkauf von 5,000 Aktien am 08/08/2025 mit Bruttoerlösen von $557,500.00. Die Mitteilung enthält die Zusicherung, dass der Verkäufer keiner nicht offengelegten wesentlichen nachteiligen Information Kenntnis hat.
- Full compliance disclosure under Rule 144 with detailed acquisition dates and quantities
- Securities originate from restricted stock vesting, indicating they were issued as compensation rather than newly created or externally purchased shares
- Broker and exchange identified (Fidelity Brokerage Services; NYSE), supporting transparent execution details
- Insider selling activity (10,000 shares valued at $1,093,990.40) may be viewed negatively by some investors
- Recent prior sale of 5,000 shares on 08/08/2025 suggests ongoing monetization of holdings
Insights
TL;DR: Routine insider notice to sell vested restricted shares; small in size relative to outstanding shares, likely not market-moving.
The Form 144 registers a proposed sale of 10,000 common shares valued at $1,093,990.40 via Fidelity on the NYSE. The filing documents that all 10,000 shares were acquired through restricted stock vesting across 2021–2024, and a prior 5,000-share sale on 08/08/2025 produced $557,500. Using the disclosed outstanding share count (74,620,227), the block equals roughly 0.013% of outstanding stock, indicating limited direct dilution or supply impact. This is a compliance disclosure under Rule 144 rather than a corporate action.
TL;DR: Disclosure shows insider monetization of compensation awards; filing follows Rule 144 mechanics and includes required seller certification.
The document lists acquisition details showing the shares originated from restricted stock vesting (compensation) in multiple tranches and includes the seller's representation about absence of undisclosed material adverse information. The presence of a recent 5,000-share sale and this 10,000-share notice is relevant for governance transparency but, given the small percentage of outstanding shares reported, the filing itself appears to be routine and procedural.
AGCO ha presentato un avviso Form 144 per registrare la proposta di vendita di 10,000 azioni ordinarie tramite Fidelity Brokerage Services sul NYSE, con un valore di mercato complessivo di $1,093,990.40 e una data di vendita approssimativa indicata al 08/11/2025. Il deposito riporta 74,620,227 azioni in circolazione, quindi il blocco da 10,000 azioni rappresenta circa il 0.013% del capitale ordinario in circolazione e implica un prezzo approssimativo di $109.40 per azione.
I titoli elencati sono stati acquisiti come restricted stock vesting in più tranche tra il 01/01/2021 e il 02/07/2024, per un totale di 10,000 azioni; il deposito indica inoltre una vendita precedente di 5,000 azioni in data 08/08/2025 con proventi lordi pari a $557,500.00. L'avviso include la dichiarazione che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate.
AGCO presentó un aviso Form 144 registrando la venta propuesta de 10,000 acciones ordinarias a través de Fidelity Brokerage Services en el NYSE, con un valor de mercado agregado de $1,093,990.40 y una fecha de venta aproximada del 08/11/2025. La presentación señala 74,620,227 acciones en circulación, por lo que el lote de 10,000 acciones representa alrededor del 0.013% del capital social en circulación e implica un precio aproximado de $109.40 por acción.
Los títulos listados fueron adquiridos como restricted stock vesting en varias tramos entre el 01/01/2021 y el 02/07/2024, por un total de 10,000 acciones, y la presentación también indica una venta previa de 5,000 acciones el 08/08/2025 con ingresos brutos de $557,500.00. El aviso incluye la declaración de que el vendedor no tiene conocimiento de información material adversa no divulgada.
AGCO는 Form 144 통지서를 제출하여 NYSE를 통해 Fidelity Brokerage Services에서 10,000 보통주를 매도할 예정임을 등록했으며, 총 시가 가치는 $1,093,990.40이고 예상 매각일은 08/11/2025로 기재되어 있습니다. 신고서에는 발행주식수 74,620,227주가 기재되어 있어 10,000주 블록은 발행주식의 약 0.013%에 해당하며 주당 약 $109.40의 가격을 의미합니다.
해당 증권은 restricted stock vesting으로 01/01/2021부터 02/07/2024 사이 여러 트랜치로 취득되어 총 10,000주이며, 신고서에는 또한 08/08/2025에 5,000주를 매각하여 총수익 $557,500.00을 올렸다고 기재되어 있습니다. 통지서에는 판매자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 진술도 포함되어 있습니다.
AGCO a déposé un avis Form 144 enregistrant la vente proposée de 10,000 actions ordinaires via Fidelity Brokerage Services sur le NYSE, pour une valeur de marché totale de $1,093,990.40 et une date de vente approximative indiquée au 08/11/2025. Le dossier indique 74,620,227 actions en circulation, de sorte que le lot de 10,000 actions représente environ 0.013% du capital ordinaire en circulation et implique un prix approximatif de $109.40 par action.
Les titres listés ont été acquis en tant que restricted stock vesting en plusieurs tranches entre le 01/01/2021 et le 02/07/2024, pour un total de 10,000 actions, et le dossier signale également une vente antérieure de 5,000 actions le 08/08/2025 pour un produit brut de $557,500.00. L'avis inclut la déclaration selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée.
AGCO hat eine Form-144-Mitteilung eingereicht, um den geplanten Verkauf von 10,000 Stammaktien über Fidelity Brokerage Services an der NYSE zu registrieren. Der Gesamtmarktwert beträgt $1,093,990.40, das ungefähre Verkaufsdatum ist mit 08/11/2025 angegeben. In der Einreichung werden 74,620,227 ausstehende Aktien genannt, sodass das 10,000-Aktien-Paket etwa 0.013% des ausstehenden Stammkapitals ausmacht und einen ungefähren Preis von $109.40 je Aktie impliziert.
Die aufgeführten Wertpapiere wurden als restricted stock vesting in mehreren Tranchen zwischen 01/01/2021 und 02/07/2024 erworben und summieren sich auf 10,000 Aktien. Die Einreichung erwähnt außerdem einen früheren Verkauf von 5,000 Aktien am 08/08/2025 mit Bruttoerlösen von $557,500.00. Die Mitteilung enthält die Zusicherung, dass der Verkäufer keiner nicht offengelegten wesentlichen nachteiligen Information Kenntnis hat.
FAQ
What does AGCO's Form 144 report?
How were the shares acquired for the sale reported in AGCO's Form 144?
How large is the proposed sale relative to AGCO's outstanding shares?
Was there any recent related selling activity disclosed?
What price per share does the filing imply for the 10,000 shares?
